ICON recognised for specialised services offering across product development lifecycle, winning five awards overall
This is the fifth year ICON has enjoyed success in the CRO Leadership Awards, having won multiple categories previously in 2020, 2019, 2018 and 2015.
ICON received 2021 CRO Leadership Awards in five of the overall six categories, each further divided into three groups – Big Pharma, Small Pharma, and Overall. In two categories, ICON achieved awards in both the Big Pharma and Overall groups.
- Capabilities (Big Pharma)
- Compatibility (Overall, Big Pharma)
- Expertise (Big Pharma)
- Reliability (Big Pharma)
- Quality (Overall, Big Pharma)
Survey participants were recruited from pharma and biopharma companies of all sizes and were screened for decision-making influence related to working with contract research organisations.
“These award winners have proven themselves to be the top service providers in each category, said
A full list of ICON’s industry awards can be viewed at www.iconplc.com/awards.
ICON is a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. ICON’s focuses on the factors that are critical to clients – reducing time to market, reducing cost and increasing quality – and its global team of experts has extensive experience in a broad range of therapeutic areas. ICON has been recognised as one of the world’s leading
This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as economic and global market conditions and other risks and uncertainties detailed from time to time in
ICON Media Contact
Telephone: +44(0)2033 538760